The NIH RADx initiative today announced the launch of the When To Test Calculator for Individuals, a companion to the version for organizations introduced last winter. By responding to just a few prompts, the new individual impact calculator indicates whether a person should get a test—now or soon.
Press Releases · November 3, 2021
Press Releases · October 26, 2021
NIH is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa. Under its new Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program.
Press Releases · October 25, 2021
NIH is investing $70 million from the American Rescue Plan to help bring more high-quality, at-home tests onto the market in the U.S. in coordination with the FDA. NIH’s new Independent Test Assessment Program (ITAP) will establish an accelerated pathway to support FDA evaluation of tests with potential for large-scale manufacturing.
Science Highlights · October 18, 2021
NIBIB-funded engineers are using deep learning to differentiate tumor more accurately from normal tissue in positron emission tomography (PET) images.
NIBIB in the News · October 15, 2021
In Ann Arbor, Mich., as in many other cities across the country, you’d be hard-pressed to find a rapid Covid-19 test today — they’re not available at the nearby Walmart or at local pharmacies. Source: STAT.
Press Releases · October 14, 2021
The NIH RADx initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.
NIBIB in the News · October 14, 2021
The National Institutes of Health's Rapid Acceleration of Diagnostics initiative announced on Thursday that it has awarded $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2. Source: Genomeweb
NIBIB in the News · October 12, 2021
SARS-CoV-2, the virus that causes COVID-19, doesn’t always cause symptoms, but people who have asymptomatic infections can unknowingly spread the disease. These asymptomatic infections may cause up to half of the viral spread in the United States. Source: NIH.gov
NIBIB in the News · October 1, 2021
National Institutes of Health Common Fund’s Bridge2AI Program Will Build Ethical, Inclusive, and Interpretable Data Sets.